Clinical Efficacy of Domestic and Imported Clopidogrel for the Treatment of Patients Received PCI Associated with Low Left Ventricu-lar Ejection Fraction
Chen Xuezhi
Tang Qiang
Wang Zhi
Qu Huaqing
Yan Dong
Abstract：Objective To observe the clinical efficacy of domestic and imported clopidogrel on blood index,clinical symptoms and long term prognosis in patients received percutaneous coronary intervention (PCI)associated with low left ventricular ejection fraction (LVEF).Methods One hundred and twenty patients with coronary artery disease(CAH)were randomly divided into two groups:Treatment group(n=60)treated by domestic clopidogrel,and control group(n=60)treated by imported clopidogrel on the basis of routine treatment for one year. The clinical symptoms,ADP IPA,electrocardiogram(ECG),LVEF were observed. Results After treatment,there was no differences in platelet count(t=0.456,P= 0.543),ADP IPA(t=1.056,P= 0.654),total clinical effective rate(χ2=2.16,P=0.19),LVEF(t=0.469,P=0.511),6 MHW (t=1.123,P=0.672)between two groups.Conclusion Domestic clopidogrel can effectively provent stent thrombosis,improve angina pectoris,increase exercise endurance,reduce readmission rates and cordis and cerebral accidents.It is cheap in price,few side effects.
Keywords：percutaneous coronary interventionleft ventricular ejection fractionclopidogrel
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：4( 615-618 )